Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
July 1, 2025
Jade Biosciences, a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, announced the appointment of Brad Dahms as Chief Financial Officer. Health Technology